Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Aging Cell ; 13(1): 49-59, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23919677

ABSTRACT

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by pathological deposits of ß-amyloid (Aß) in senile plaques, intracellular neurofibrillary tangles (NFTs) comprising hyperphosphorylated aggregated tau, synaptic dysfunction and neuronal death. Substantial evidence indicates that disrupted neuronal calcium homeostasis is an early event in AD that could mediate synaptic dysfunction and neuronal toxicity. Sodium calcium exchangers (NCXs) play important roles in regulating intracellular calcium, and accumulating data suggests that reduced NCX function, following aberrant proteolytic cleavage of these exchangers, may contribute to neurodegeneration. Here, we show that elevated calpain, but not caspase-3, activity is a prominent feature of AD brain. In addition, we observe increased calpain-mediated cleavage of NCX3, but not a related family member NCX1, in AD brain relative to unaffected tissue and that from other neurodegenerative conditions. Moreover, the extent of NCX3 proteolysis correlated significantly with amounts of Aß1-42. We also show that exposure of primary cortical neurons to oligomeric Aß1-42 results in calpain-dependent cleavage of NCX3, and we demonstrate that loss of NCX3 function is associated with Aß toxicity. Our findings suggest that Aß mediates calpain cleavage of NCX3 in AD brain and therefore that reduced NCX3 activity could contribute to the sustained increases in intraneuronal calcium concentrations that are associated with synaptic and neuronal dysfunction in AD.


Subject(s)
Alzheimer Disease/enzymology , Alzheimer Disease/pathology , Amyloid beta-Peptides/metabolism , Calpain/metabolism , Sodium-Calcium Exchanger/metabolism , Aged , Aged, 80 and over , Amyloid beta-Peptides/toxicity , Animals , Brain/drug effects , Brain/enzymology , Brain/pathology , Calcium-Binding Proteins/metabolism , Caspase 3/metabolism , Cells, Cultured , Female , Gene Knockdown Techniques , Humans , Male , Middle Aged , Oligonucleotides, Antisense/pharmacology , Postmortem Changes , Protein Subunits/metabolism , Rats , Spectrin/metabolism , Substrate Specificity/drug effects , Tauopathies/enzymology , Tauopathies/pathology
2.
Biochem J ; 441(2): 579-90, 2012 Jan 15.
Article in English | MEDLINE | ID: mdl-21955321

ABSTRACT

Aß42 [amyloid-ß peptide-(1-42)] plays a central role in Alzheimer's disease and is known to have a detrimental effect on neuronal cell function and survival when assembled into an oligomeric form. In the present study we show that administration of freshly prepared Aß42 oligomers to a neuroblastoma (SH-SY5Y) cell line results in a reduction in survival, and that Aß42 enters the cells prior to cell death. Immunoconfocal and immunogold electron microscopy reveal the path of the Aß42 with time through the endosomal system and shows that it accumulates in lysosomes. A 24 h incubation with Aß results in cells that have damaged lysosomes showing signs of enzyme leakage, accumulate autophagic vacuoles and exhibit severely disrupted nuclei. Endogenous Aß is evident in the cells and the results of the present study suggest that the addition of Aß oligomers disrupts a crucial balance in Aß conformation and concentration inside neuronal cells, resulting in catastrophic effects on cellular function and, ultimately, in cell death.


Subject(s)
Amyloid beta-Peptides/pharmacology , Autophagy/physiology , Neuroblastoma/pathology , Peptide Fragments/pharmacology , Alzheimer Disease/physiopathology , Amyloid beta-Peptides/metabolism , Cathepsin D/metabolism , Cell Line, Tumor , Clathrin/metabolism , Hippocampus/metabolism , Humans , Lysosomes/pathology , Microscopy, Confocal , Microscopy, Electron, Transmission , Neuroblastoma/metabolism , Peptide Fragments/metabolism
3.
J Neural Transm (Vienna) ; 115(12): 1661-71, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18974920

ABSTRACT

TAR DNA-binding protein of 43 kDa (TDP-43) is a major component of the pathological inclusions of frontotemporal lobar degeneration with TDP-43 proteinopathy, also called FTLD with ubiquitin-positive, tau-negative inclusions (FTLD-U), and motor neuron disease (MND). TDP-43 is predominantly expressed in the nucleus and regulates gene expression and splicing. In FTLD with TDP-43 proteinopathy, neuronal inclusions present variably as cytoplasmic inclusions (NCIs), dystrophic neurites (DNs), and intranuclear inclusions (NIIs), leading to a fourfold neuropathological classification correlating with genotype. There have been few fine structural studies of these inclusions. Thus, we undertook an immunoelectron microscopic study of FTLD with TDP-43 proteinopathy, including sporadic and familial cases with progranulin (GRN) mutation. TDP-43-immunoreactive inclusions comprised two components: granular and filamentous. Filament widths, expressed as mean (range) were: NCI, 9 nm (4-16 nm); DN, 10 nm (5-16 nm); NII, 18 nm (9-50 nm). Morphologically distinct inclusion components may reflect the process of TDP-43 aggregation and interaction with other proteins: determining these latter may contribute towards understanding the heterogeneous pathogenesis of FTLD with TDP-43 proteinopathy.


Subject(s)
Brain/pathology , DNA-Binding Proteins/metabolism , Dementia/pathology , Genetic Predisposition to Disease/genetics , Inclusion Bodies/pathology , Neurons/pathology , Aged , Aged, 80 and over , Brain/metabolism , Brain/physiopathology , Cell Nucleus/metabolism , Cell Nucleus/pathology , Cytoplasm/metabolism , Cytoplasm/pathology , DNA Mutational Analysis , DNA-Binding Proteins/genetics , Dementia/genetics , Dementia/metabolism , Female , Genetic Testing , Humans , Inclusion Bodies/genetics , Inclusion Bodies/metabolism , Intercellular Signaling Peptides and Proteins/genetics , Male , Microscopy, Immunoelectron , Mutation/genetics , Neurons/metabolism , Progranulins
SELECTION OF CITATIONS
SEARCH DETAIL
...